SNOA - Sonoma Pharmaceuticals, Inc. News

Sectors

SNOA

Sonoma Pharmaceuticals, Inc.

1.44

1 x 1.40

5 x 1.45

bid

ask

0.19

15.20%

1 @ 04:00 PM

1.43 -0.01 (0.69%)

Ytd	-60.44%
1y	-53.70%

1.23

day range

1.45

1.01

52 week range

5.35

Open	1.28	Prev Close	1.25	Low	1.23	High	1.45	Mkt Cap	2.42M
Vol	1.05M	Avg Vol	121.28K	EPS	-1.18	P/E	-1.22	Forward P/E	-1.49
Beta	1.38	Short Ratio	0.22	Inst. Own	2.42%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	08-11	50-d Avg	1.16	200-d Avg	2.45	1yr Est	19.50

SNOA News

accessnewswire.com

Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and Firs

Total revenue increased 60% year over year to $6.4 million Net loss per share decreased 88% compared

benzinga.com

Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue

Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) on Thursday posted a first-quarter loss of 9 cents per sha

accessnewswire.com

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for

BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global

accessnewswire.com

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results

Revenues increased 48% in Q4 2026 compared to Q4 2025, and 37% in FY 2026 compared to FY 2025 United

defenseworld.net

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Short Interest Update

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA - Get Free Report) was the recipient of a significant dec

benzinga.com

12 Health Care Stocks Moving In Friday's Intraday Session

accessnewswire.com

Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

BOULDER, CO / ACCESS Newswire / April 24, 2026 / Sonoma Pharmaceuticals, Inc. (the "Company" or "Son

benzinga.com

12 Health Care Stocks Moving In Friday's Pre-Market Session

feeds.benzinga.com

Sonoma Pharmaceuticals (SNOA) Jumps 16% After Hours On Burn Relief Hydrogel Launch In Walmart, CVS

Sonoma Pharmaceuticals jumps over 16% in after-hours trading following the U.S. retail launch of its

accessnewswire.com

Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walm

BOULDER, CO / ACCESS Newswire / March 24, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a globa

accessnewswire.com

Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquan

BOULDER, CO / ACCESS Newswire / March 18, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a globa

accessnewswire.com

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended Dece

accessnewswire.com

Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President o

BOULDER, CO / ACCESS Newswire / January 28, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a glo

defenseworld.net

Head to Head Comparison: Ocular Therapeutix (NASDAQ:OCUL) & Sonoma Pharmaceuticals (NASDAQ:SNOA)

Sonoma Pharmaceuticals (NASDAQ: SNOA - Get Free Report) and Ocular Therapeutix (NASDAQ: OCUL - Get F

defenseworld.net

Sonoma Pharmaceuticals (NASDAQ:SNOA) Share Price Passes Above 200-Day Moving Average – Time to Sel

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA - Get Free Report)'s stock price passed above its two hun

accessnewswire.com

National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a gl

accessnewswire.com

Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

BOULDER, CO / ACCESS Newswire / November 6, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a glo

accessnewswire.com

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results

Revenues increased 57% for the quarter and 38% for the six months ended September 30, 2025 compared

accessnewswire.com

Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals

BOULDER, CO / ACCESS Newswire / October 14, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a glo

accessnewswire.com

Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Micr

BOULDER, COLORADO / ACCESS Newswire / October 7, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA),

accessnewswire.com

Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on Septem

BOULDER, COLORADO / ACCESS Newswire / September 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA

accessnewswire.com

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Ad

BOULDER, CO / ACCESS Newswire / August 26, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a glob

benzinga.com

12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com

Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Prema